Demant

Demant, a surgical and medical instrument manufacturing company headquartered in DK, reported a total of approximately 221.8 million kg CO2e in 2025. This figure comprises approximately 15.9 million kg CO2e from Scope 1 emissions, and approximately 10.9 million kg CO2e from Scope 2 emissions (market-based). Scope 3 emissions were the largest contributor, accounting for approximately 195 million kg CO2e, with purchased goods and services being the most significant category at approximately 133.7 million kg CO2e.

In 2024, Demant's total emissions were approximately 238.7 million kg CO2e. This included approximately 14.6 million kg CO2e in Scope 1, and approximately 14.8 million kg CO2e in Scope 2 (market-based). Scope 3 emissions for 2024 were approximately 209.3 million kg CO2e, with purchased goods and services representing the largest portion at approximately 156 million kg CO2e.

Demant has set ambitious climate targets. The company aims for a 46% reduction in absolute Scope 1 and 2 greenhouse gas (GHG) emissions by 2030, using a 2019 baseline. Similarly, they are targeting a 46% reduction in absolute Scope 3 GHG emissions by 2030, also from a 2019 baseline. Furthermore, Demant is committed to reaching net-zero GHG emissions across its entire value chain by 2050. Their long-term targets include a 90% reduction in absolute Scope 1 and 2 GHG emissions by 2050, and a 90% reduction in absolute Scope 3 GHG emissions by 2050, both from the 2019 baseline.